Managing microbial dysbiosis with temocillin
US12396984B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 2020 |
| Grant date | Aug 26, 2025 |
| Priority date | — |
| Expiry date | Nov 3, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of using temocillin to control microbial dysbiosis arising from, in certain instances, enterobacteriacea overgrowth such as overgrowth from adherent invasive E. coli (AIEC). Methods of using temocillin to treat intestinal disorders and symptoms of such caused by microbial dysbiosis, as well as other disorders are contemplated herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.